FIELD: pharmacology.
SUBSTANCE: invention relates to a synergistic pharmaceutical composition with anti-tuberculosis activity, containing cycloserine and a zinc-containing compound as active principle.
EFFECT: composition of the invention is characterized by increased anti-tuberculosis activity, pharmacokinetics and reduced toxicity.
17 cl, 6 ex, 12 tbl, 2 dwg
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL ANTI-TUBERCULOSIS COMBINED COMPOSITION | 2011 |
|
RU2478389C2 |
COMBINED ANTI-TUBERCULOSIS PREPARATION | 2007 |
|
RU2354378C1 |
COMBINED ANTITUBERCULOUS COMPOSITION | 2010 |
|
RU2468802C2 |
ANTI-TUBERCULOSIS MEDICATION BASED ON 4-THIOUREIDOIMINOMETHYLPYRIDINIUM PERCHLORATE, METHOD OF ITS OBTAINING AND METHOD OF TREATMENT | 2010 |
|
RU2423977C1 |
COMBINED ANTITUBERCULOUS COMPOSITION | 2009 |
|
RU2413517C1 |
COMPOSITE FORMULATION WITH ANTITUBERCULOUS ACTIVITY | 2003 |
|
RU2247560C1 |
COFORMULATED ANTITUBERCULOUS DRUG | 2009 |
|
RU2430724C2 |
ANTITUBERCULOUS AGENT | 2003 |
|
RU2247559C1 |
COMBINED THERAPY OF TUBERCULOSIS | 2009 |
|
RU2484819C2 |
ANTITUBERCULOSIS PHARMACEUTICAL COMPOSITION CONTAINING THIOACETAZONE | 2015 |
|
RU2627611C2 |
Authors
Dates
2017-05-30—Published
2016-03-01—Filed